Human ELISA Detects anti-SARS-CoV-2 Antibodies in Cats: Seroprevalence and Risk Factors for Virus Spread in Domestic and Stray Cats in Bulgaria

被引:6
|
作者
Sirakov, Ivo [1 ]
Rusenova, Nikolina [2 ]
Rusenov, Anton [3 ]
Gergova, Raina [1 ]
Strateva, Tanya [1 ]
机构
[1] Med Univ Sofia, Med Fac, Dept Med Microbiol, Sofia 1431, Bulgaria
[2] Trakia Univ, Fac Vet Med, Dept Vet Microbiol Infect & Parasit Dis, Stara Zagora 6000, Bulgaria
[3] Trakia Univ, Fac Vet Med, Dept Internal Noninfect Dis, Stara Zagora 6000, Bulgaria
关键词
ELISA; SARS-CoV-2; antibodies; humans; cats; SARS-COV-2; DIAGNOSIS;
D O I
10.3390/vetsci10010042
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Simple Summary The aim of the study was to verify whether the human DR-ELISA for the detection of antibodies against the agent of COVID-19 can be applied in cats, as well as to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. Therefore, 92 serum samples collected from 68 domestic and 24 stray cats were analyzed and compared with a multi-species ELISA kit. The results showed 83.33% positive results in stray cats and 41.18% in domestic cats, respectively, by both assays. Cats under 7 years had a five times higher risk than those over 7 years. The risk was seven times higher for stray cats than for domestic cats. Additionally, the results indicate the highest risk for cats in villages. This study demonstrates that human DR-ELISA may be helpful in monitoring the circulation of the virus in cats. The aim of this study was to verify whether the human DR-ELISA for the detection of anti-SARS-CoV-2 antibodies can be applied in cats, and to assess the risk factors that determine the spread of the virus among the cat population in Bulgaria. The study included 92 serum samples collected from 68 domestic and 24 stray cats aged from 3 months to 20 years of age in the period of January-June 2021. The samples originated from three regions in Bulgaria and from three places of inhabitance. DR-ELISA based on peroxidase-labeled SARS-CoV-2 N protein was employed to detect IgA, IgG and IgM antibodies in the samples. Subsequently, the results were compared with a commercially available multi-species ELISA kit. There was high seroprevalence (83.33%) in stray cats and 41.18% in domestic cats, confirmed by the human and veterinary ELISA kit. The positive cases in the regional cities were 42.86%, in small towns 50% and in villages 78.26%. Cats under 7 years had a five times higher risk than those over 7 years (p = 0.001). The risk was seven times higher for stray cats than for domestic cats (p = 0.001). In addition, the results indicate that the risk was the highest for cats in villages (p = 0.006) compared to cats in other places of inhabitance. This study demonstrates that human DR-ELISA may be successfully applied to monitor the circulation of SARS-CoV-2 in cats and other susceptible species. Cats might serve as sentinel animals for tracking the virus in nature and in inhabited areas (strays) and to discover asymptomatic cases in humans/owners.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The Second Round of a Population-Based Seroprevalence Study of Anti-SARS-CoV-2 Antibodies and COVID-19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
    Acimovic, Jela
    Mijovic, Biljana
    Masic, Srdan
    Petkovic, Miroslav
    Sladoje, Dragana Puhalo
    Knezevic, Darija
    Devic, Jelena Dakovic
    Spaic, Dragan
    Vladicic-Masic, Jelena
    Bokonjic, Dejan
    Palo, Mirza
    Vaughan, Aisling
    Pebody, Richard
    Nardone, Anthony
    Skrbic, Ranko
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2025, 19 (01)
  • [42] Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study
    Zaballa, Maria-Eugenia
    Perez-Saez, Javier
    de Mestral, Carlos
    Pullen, Nick
    Lamour, Julien
    Turelli, Priscilla
    Raclot, Charlene
    Baysson, Helene
    Pennacchio, Francesco
    Villers, Jennifer
    Duc, Julien
    Richard, Viviane
    Dumont, Roxane
    Semaani, Claire
    Loizeau, Andrea Jutta
    Graindorge, Clement
    Lorthe, Elsa
    Balavoine, Jean-Francois
    Pittet, Didier
    Schibler, Manuel
    Vuilleumier, Nicolas
    Chappuis, Francois
    Kherad, Omar
    Azman, Andrew S.
    Posfay-Barbe, Klara M.
    Kaiser, Laurent
    Trono, Didier
    Stringhini, Silvia
    Guessous, Idris
    LANCET REGIONAL HEALTH-EUROPE, 2023, 24
  • [43] The dynamics of neutralizing antibodies against SARS-CoV-2 in cats naturally exposed to virus reveals an increase in antibody activity after re-infection
    Villanueva-Saz, Sergio
    Martinez, Marivi
    Rueda, Pablo
    Bolea, Sara
    Perez, Maria Dolores
    Verde, Maite
    Yzuel, Andres
    Hurtado-Guerrero, Ramon
    Pardo, Julian
    Santiago, Llipsy
    Fernandez, Antonio
    Arias, Maykel
    VETERINARY RESEARCH COMMUNICATIONS, 2023, 47 (04) : 2179 - 2184
  • [44] The dynamics of neutralizing antibodies against SARS-CoV-2 in cats naturally exposed to virus reveals an increase in antibody activity after re-infection
    Sergio Villanueva-Saz
    Marivi Martínez
    Pablo Rueda
    Sara Bolea
    María Dolores Pérez
    Maite Verde
    Andrés Yzuel
    Ramón Hurtado-Guerrero
    Julián Pardo
    Llipsy Santiago
    Antonio Fernández
    Maykel Arias
    Veterinary Research Communications, 2023, 47 : 2179 - 2184
  • [45] Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA
    Kulkarni, Ruta
    Patil, Harshad P.
    Palkar, Sonali
    Lalwani, Sanjay
    Mishra, Akhilesh Chandra
    Arankalle, Vidya
    JOURNAL OF VIROLOGICAL METHODS, 2021, 287
  • [46] An Optimised Indirect ELISA Protocol for Detection and Quantification of Anti-viral Antibodies in Human Plasma or Serum: A Case Study Using SARS-CoV-2
    Baine, Claire
    Sembera, Jackson
    Oluka, Gerald Kevin
    Katende, Joseph Ssebwana
    Ankunda, Violet
    Serwanga, Jennifer
    BIO-PROTOCOL, 2023, 13 (24):
  • [47] Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review
    Dimitroglou, Margarita
    Sokou, Rozeta
    Iacovidou, Nicoletta
    Pouliakis, Abraham
    Kafalidis, Georgios
    Boutsikou, Theodora
    Iliodromiti, Zoi
    NUTRIENTS, 2023, 15 (08)
  • [48] Fcγ-Receptor-Based Enzyme-Linked Immunosorbent Assays for Sensitive, Specific, and Persistent Detection of Anti-SARS-CoV-2 Nucleocapsid Protein IgG Antibodies in Human Sera
    Deschermeier, Christina
    Ehmen, Christa
    von Possel, Ronald
    Murawski, Carolin
    Ben Rushton
    Amuasi, John
    Sarpong, Nimako
    Maiga-Ascofare, Oumou
    Rakotozandrindrainy, Raphael
    Asogun, Danny
    Ighodalo, Yemisi
    Oestereich, Lisa
    Duraffour, Sophie
    Pahlmann, Meike
    Emmerich, Petra
    JOURNAL OF CLINICAL MICROBIOLOGY, 2022, 60 (06)
  • [49] Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
    Cristiano, Antonio
    Pieri, Massimo
    Sarubbi, Serena
    Pelagalli, Martina
    Calugi, Graziella
    Tomassetti, Flaminia
    Bernardini, Sergio
    Nuccetelli, Marzia
    CLINICAL IMMUNOLOGY, 2022, 234
  • [50] Development of chemiluminescent lab-on-fiber immunosensors for rapid point-of-care testing of anti-SARS-CoV-2 antibodies and evaluation of longitudinal immune response kinetics following three-dose inactivation virus vaccination
    Xu, Wenjuan
    Song, Dan
    Liu, Jiayao
    Han, Xiangzhi
    Xu, Jiaxin
    Zhu, Anna
    Long, Feng
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)